• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Handbook of Biologics & Biosimilars in Dermatology

Handbook of Biologics & Biosimilars in Dermatology

9789352703647
218.40 zł
196.56 zł Save 21.84 zł Tax included
Lowest price within 30 days before promotion: 196.56 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

A drug is typically manufactured through chemical synthesis, which means that it is made by combining specific chemical ingredients in an ordered process. Biologics are medicines made from living cells through highly complex manufacturing processes and must be handled and administered under carefully monitored conditions. Biologics are used to prevent, treat, diagnose, or cure a variety of diseases including cancer, chronic kidney disease, autoimmune disorders, and infectious diseases. A biosimilar is a biologic that is similar to another biologic drug already that has already been approved.

This book is a complete guide to the use of biologics and biosimilars in the treatment of dermatologic disorders.

Beginning with an overview of the history and classification of biologics and the concept of biosimilars, the following chapters explain their therapeutic use for different skin conditions.

The final sections cover related topics such as cost effectiveness and quality of life with biologic therapy, and the book concludes with discussion on future developments and the use of small molecule treatment.

Key points

  • Complete guide to use of biologics and biosimilars in treatment of dermatologic disorders
  • Covers many different skin diseases and conditions
  • Discusses related topics such as cost effectiveness and quality of life
  • Covers future development of small molecule therapy
Product Details
96155
9789352703647
9789352703647

Data sheet

Publication date
2018
Issue number
1
Cover
paperback
Pages count
419
Dimensions (mm)
159.00 x 241.00
Weight (g)
250
    1. History and Development of biologics
    2. Classification of Biologics
    3. Concept and development of biosimilars
    4. Biologics in management of psoriasis - Pathogenesis and mechanism of action
    5. TNF alpha Blockers
      1. Etanercept Infliximab
      2. Adalimumab
    6. IL-17 blockers - Secukinumab
    7. Anti CD6 monoclonal antibody
    8. Newer biologics
    9. Anti CD20 monoclonal antibody
    10. Anti IgE monoclonal antibody
    11. Intravenous immunoglobulins
    12. Miscellaneous uses of biologics
    13. Biologic approach to management of various diseases - when to use and which one?
      1. Psoriasis
      2. Immunobullous diseases
      3. Hidradenitis suppurativa
      4. Connective tissue diseases
    14. Adverse effects of biologics - feared or real?
    15. Management of latent tuberculosis infection
    16. Adult immunization prior to initiation of biologic therapy
    17. Cost effectiveness and quality of life with biologic therapy
    18. Biologics in children:: Which, when, why?
    19. Biologics in presence of hepatitis B and C infection
    20. Biologics in special situation
    21. Small molecules
      1. Tofacitinib
      2. Apremilast
      3. Sirolimus
Comments (0)